HCA Healthcare (NYSE:HCA) Releases Earnings Results, Beats Expectations By $0.57 EPS

HCA Healthcare (NYSE:HCA) issued its quarterly earnings results on Tuesday. The company reported $7.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57, FiscalAI reports. The company had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. HCA Healthcare’s revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the company earned $6.96 EPS.

HCA Healthcare Stock Performance

NYSE:HCA opened at $480.52 on Tuesday. The company has a 50-day moving average of $431.57 and a 200-day moving average of $445.15. The company has a market capitalization of $104.03 billion, a price-to-earnings ratio of 16.09, a PEG ratio of 1.58 and a beta of 1.10. HCA Healthcare has a 52 week low of $353.99 and a 52 week high of $556.52.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. TD Cowen increased their price objective on HCA Healthcare from $431.00 to $460.00 and gave the company a “buy” rating in a research report on Monday, October 12th. JPMorgan Chase & Co. decreased their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a report on Thursday, August 20th. Weiss Ratings upgraded HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Truist Financial dropped their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th. Finally, BMO Capital Markets initiated coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 price objective on the stock. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $467.50.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA reported quarterly earnings of $7.22 per share, above the $6.65 analyst consensus, while revenue reached $19.85 billion versus expectations of $19.33 billion. The results reflect continued demand for hospital and healthcare services. HCA Healthcare beats quarterly profit estimates on demand for medical services
• Positive Sentiment: The company maintained its existing financial guidance, which suggests management remains confident in its outlook despite ongoing cost and operating pressures. HCA Healthcare posts solid Q3 results, maintains guidance
• Neutral Sentiment: Analyst fair-value estimates moved in mixed directions, producing only a modest improvement in the aggregate valuation outlook rather than a clear new bullish catalyst. HCA Healthcare Stock Fair Value Edges Higher After Mixed Analyst Target Changes
• Negative Sentiment: Net income declined to $1.58 billion from $1.64 billion in the prior-year quarter. The profit decline, despite higher revenue, highlights margin pressure and helps explain why the earnings reaction has been muted. HCA Healthcare Profit Slips but Revenue Rises
• Negative Sentiment: Potential changes to hospital laws and government funding policies could create uncertainty for HCA’s rural and regional operations, although the near-term financial impact is unclear. Trump dangles rural health dollars to push states to change hospital laws

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.